How will a 22-year-old female with type 1 (insulin-dependent) diabetes, gravida 1, para 0, at 12 weeks gestation, be managed and what effects can her diabetes have on her pregnancy and newborn?

Management of Type 1 Diabetes in Pregnancy

1. How Pregnancy Will Affect Her Diabetes

Pregnancy will dramatically alter this patient's insulin requirements in a triphasic pattern, with initial decreased needs in the first trimester followed by exponential increases requiring weekly dose adjustments through week 36, typically doubling her total daily insulin dose. 1

First Trimester (Current - Week 12)

• Insulin requirements will decrease due to enhanced insulin sensitivity and lower glucose levels 1
• Hypoglycemia risk is significantly elevated during this period, requiring intensive education for the patient and family on prevention, recognition, and treatment 1
• Hypoglycemia awareness may be impaired due to altered counterregulatory responses in pregnancy 1

Second and Third Trimesters (Weeks 16-36)

• Insulin resistance increases exponentially starting around week 16 due to diabetogenic placental hormones 1
• Insulin doses must increase approximately 5% per week through week 36, often doubling pre-pregnancy requirements 1
• Insulin requirements plateau toward the end of the third trimester with placental aging 1

Critical Metabolic Changes

• Fasting hypoglycemia occurs due to insulin-independent glucose uptake by the placenta 1
• Postprandial hyperglycemia and carbohydrate intolerance develop as a result of diabetogenic placental hormones 1
• Pregnancy is a ketogenic state, placing women with type 1 diabetes at risk for diabetic ketoacidosis at lower blood glucose levels than when not pregnant 1

---

2. Changes Needed in Diabetes Management

She must immediately transition to intensive glucose monitoring with fasting and postprandial checks (not just twice daily), adjust insulin dosing weekly starting at 16 weeks, and achieve stricter glycemic targets than her pre-pregnancy goals. 1

Glucose Monitoring Requirements

• Switch from twice-daily to fasting and postprandial monitoring (either 1-hour or 2-hour post-meal) 1
• Preprandial testing is also required when using basal-bolus therapy to adjust premeal rapid-acting insulin 1
• Consider continuous glucose monitoring (CGM), which has demonstrated improved A1C without increased hypoglycemia, plus reductions in large-for-gestational-age births, neonatal hypoglycemia, and length of stay 1

Glycemic Targets (Stricter Than Pre-Pregnancy)

• Fasting glucose: 70-95 mg/dL (3.9-5.3 mmol/L) 1
• One-hour postprandial: 110-140 mg/dL (6.1-7.8 mmol/L) 1
• Two-hour postprandial: 100-120 mg/dL (5.6-6.7 mmol/L) 1
• A1C target: <6% (42 mmol/mol) if achievable without significant hypoglycemia 1

Insulin Regimen Adjustments

• A smaller proportion of total daily dose should be basal insulin, with a greater proportion as prandial insulin 1
• Weekly or biweekly insulin dose increases will be required starting in the second trimester 1
• Insulin pump consideration should be revisited, as it may facilitate the frequent dose adjustments needed 1

Medication Review

• Immediately discontinue ACE inhibitors or ARBs if she is taking them (teratogenic, associated with fetal renal anomalies, oligohydramnios, and fetal death) 2
• Stop statins immediately if prescribed (pregnancy category X) 2
• Switch antihypertensives to methyldopa, labetalol, or long-acting nifedipine if needed 2

Additional Management

• Obtain ketone strips for home use and educate on diabetic ketoacidosis prevention and detection 1
• Medical nutrition therapy should be optimized with a registered dietitian 2

---

3. Routine Assessments at Each Prenatal Visit

Every prenatal visit must include review of blood glucose logs with fasting and postprandial values, assessment for hypoglycemia episodes, and weekly insulin dose adjustments starting at 16 weeks. 1

Glucose Control Assessment

• Review self-monitored blood glucose logs showing fasting and postprandial values 1
• Assess frequency and severity of hypoglycemic episodes 1
• Evaluate adherence to dietary recommendations 1

Insulin Dose Management

• Adjust insulin doses weekly or biweekly starting around 16 weeks gestation 1
• Monitor for rapid reduction in insulin requirements, which can indicate placental insufficiency 1

Maternal Comorbidity Screening

• Blood pressure monitoring at every visit (target 110-135/85 mmHg) 2
• Assess for signs/symptoms of preeclampsia (diabetes increases risk) 1, 3
• Weight gain monitoring (individualized based on pre-pregnancy BMI) 1

A1C Monitoring

• Check A1C monthly (more frequently than usual due to altered red blood cell kinetics in pregnancy) 1
• Use A1C as a secondary measure after self-monitoring of blood glucose, as it may not fully capture postprandial hyperglycemia 1

---

4. Additional Tests as Pregnancy Progresses

She requires baseline ophthalmology exam in the first trimester, repeat retinal exams each trimester, serial fetal growth ultrasounds starting at 28 weeks, and antenatal testing beginning at 32 weeks. 1, 2, 3

First Trimester (Already at 12 Weeks)

• Comprehensive ophthalmologic exam to assess for diabetic retinopathy 1, 2
• Thyroid-stimulating hormone (TSH) 1, 2
• Serum creatinine and urine albumin-to-creatinine ratio to assess for diabetic nephropathy 1, 2
• Early ultrasound for dating and baseline fetal assessment 3

Second Trimester

• Repeat ophthalmologic exam (rapid implementation of tight glycemic control can worsen retinopathy) 1
• Fetal anatomic survey at 18-20 weeks to screen for congenital malformations, especially cardiac, neural tube, and musculoskeletal defects 1, 3, 4
• Fetal echocardiography at 20-22 weeks (increased risk of congenital heart disease) 1, 4

Third Trimester

• Serial fetal growth ultrasounds starting at 28 weeks (every 3-4 weeks) to monitor for macrosomia or growth restriction 3, 4
• Antenatal testing (non-stress tests or biophysical profiles) beginning at 32 weeks (earlier if complications present) 3, 5
• Repeat ophthalmologic exam in the third trimester 1

Throughout Pregnancy

• Monthly A1C monitoring 1
• Urine protein assessment at each trimester if baseline nephropathy present 2

---

5. How the Fetus May Be Affected

Her fetus faces increased risks of major congenital malformations (especially cardiac and neural tube defects), macrosomia, intrauterine growth restriction if maternal vasculopathy develops, and stillbirth, with severity directly correlated to her glycemic control. 1, 3, 4

Congenital Malformations (First Trimester Risk)

• Risk increases directly with elevations in periconceptional and first-trimester A1C 1, 2
• Most common malformations: anencephaly, microcephaly, congenital heart disease, musculoskeletal defects, and limb abnormalities 1, 4
• Spontaneous abortion risk is also increased with uncontrolled diabetes 1, 4

Fetal Growth Abnormalities

• Macrosomia (large-for-gestational-age) is the most common complication, resulting from fetal hyperinsulinism in response to maternal hyperglycemia 6, 3, 4
• Intrauterine growth restriction can occur if maternal diabetic vasculopathy (especially nephropathy) is present 1, 3

Intrauterine Fetal Demise

• Stillbirth risk is increased, particularly in the third trimester with poor glycemic control 1, 6, 3
• Severe fasting hyperglycemia during the last 4-8 weeks specifically increases stillbirth risk 6

Fetal Hyperinsulinism Consequences

• Increased fetal adiposity and organomegaly (especially cardiac hypertrophy) 3, 4
• Delayed lung maturity leading to respiratory distress syndrome 3, 4
• Polycythemia from chronic hypoxia 3

Long-Term Offspring Effects

• Increased risk of obesity, glucose intolerance, and type 2 diabetes in late adolescence and young adulthood 1, 4
• Higher incidence of neurodevelopmental problems, including ADHD and autism spectrum disorder 4

---

6. Nursing Management During Labor

Intravenous insulin and dextrose infusion protocols are necessary during labor to maintain maternal glucose between 80-110 mg/dL, with hourly glucose monitoring and immediate postpartum insulin dose reduction due to rapid return of insulin sensitivity after placental delivery. 5

Glycemic Control During Labor

• Target maternal glucose: 80-110 mg/dL during labor 5
• Low-dose intravenous insulin and dextrose protocols are necessary for women with type 1 diabetes 5
• Hourly capillary glucose monitoring during active labor 5

Insulin Pump Management (If Applicable)

• If she pursues insulin pump use before delivery, self-managed continuous subcutaneous insulin infusion (CSII) requires intensive education and coordination with the labor team 5
• Alternative: transition to IV insulin protocol upon admission to labor and delivery 5

Immediate Postpartum Considerations

• Insulin sensitivity increases dramatically with delivery of the placenta 1
• Insulin requirements drop rapidly and may initially be much lower than pre-pregnancy levels 1
• Women become very insulin sensitive immediately following delivery, requiring significant dose reductions to prevent hypoglycemia 1

Monitoring for Complications

• Monitor for diabetic ketoacidosis, which can develop at lower glucose levels in pregnancy 1
• Assess for hypokalemia with IV insulin administration (can cause respiratory paralysis, ventricular arrhythmia, and death if untreated) 7
• Potassium levels must be monitored closely when insulin is administered intravenously 7

---

7. Anticipated Newborn Problems

The nurse should anticipate neonatal hypoglycemia (occurring in 10-40% of infants), respiratory distress syndrome, hyperbilirubinemia, polycythemia, hypocalcemia, and potential cardiac hypertrophy requiring NICU admission. 1, 6, 3, 4

Neonatal Hypoglycemia (Most Common)

• Occurs in 10-40% of infants born to mothers with poorly controlled diabetes 6
• Results from fetal hyperinsulinism that persists after birth when maternal glucose supply stops 6, 3
• Typically resolves within 24-48 hours postpartum 6
• Requires immediate glucose monitoring after delivery and frequent monitoring for first 24-48 hours 3

Respiratory Complications

• Respiratory distress syndrome due to delayed lung maturity from fetal hyperinsulinism 3, 4
• Transient tachypnea of the newborn 3
• Higher rates of NICU admission for respiratory support 3

Metabolic Complications

• Hyperbilirubinemia requiring phototherapy 1, 3
• Hypocalcemia 3
• Hypomagnesemia 3

Hematologic Issues

• Polycythemia from chronic intrauterine hypoxia 3, 4
• Increased risk of thrombosis 3

Cardiac Complications

• Cardiomyopathy (hypertrophic) from fetal hyperinsulinism 1, 4
• Congenital heart defects if first-trimester glycemic control was poor 1, 4

Perinatal Mortality

• Increased risk of perinatal death and stillbirth, especially with poor maternal glycemic control 1, 3, 4

---

8. Added Care the Infant Will Need

The infant requires immediate and frequent glucose monitoring for 24-48 hours, NICU-level observation for respiratory distress and metabolic complications, echocardiography if cardiac hypertrophy is suspected, and close follow-up for long-term metabolic and neurodevelopmental risks. 6, 3, 4

Immediate Postnatal Care

• Glucose monitoring within 30 minutes of birth, then every 1-2 hours for the first 24-48 hours until stable 6, 3
• Early feeding initiation to prevent hypoglycemia 3
• IV dextrose administration if hypoglycemia cannot be corrected with feeding 3

NICU Admission Criteria

• Respiratory distress requiring oxygen support or continuous positive airway pressure 3, 4
• Persistent hypoglycemia despite feeding 6, 3
• Symptomatic polycythemia requiring partial exchange transfusion 3
• Cardiac complications requiring monitoring or intervention 4

Specialized Assessments

• Echocardiography if cardiac hypertrophy or murmur detected 4
• Chest X-ray if respiratory distress present 3
• Complete blood count to assess for polycythemia 3
• Serum calcium and magnesium levels 3
• Bilirubin monitoring for hyperbilirubinemia 1, 3

Breastfeeding Support

• All women should be supported in breastfeeding, given immediate nutritional and immunological benefits for the baby 1
• Potential longer-term metabolic benefit to both mother and offspring 1
• Mother may require insulin dose adjustments due to erratic sleep and eating schedules with breastfeeding 1

Long-Term Follow-Up

• Monitor for childhood obesity and metabolic syndrome (increased risk in offspring of diabetic mothers) 1, 4
• Neurodevelopmental screening for ADHD and autism spectrum disorder 4
• Glucose tolerance assessment in adolescence and young adulthood 1, 4

---

Critical Pitfalls to Avoid

• Do not wait until symptoms develop to adjust insulin doses - weekly increases are needed starting at 16 weeks regardless of current control 1
• Do not rely solely on A1C - it falls physiologically in pregnancy and doesn't capture postprandial hyperglycemia that drives macrosomia 1
• Do not ignore hypoglycemia risk in the first trimester - this is when insulin sensitivity is highest and hypoglycemia awareness is impaired 1
• Do not assume rapid glycemic control improvement is always good - it can worsen retinopathy if she has baseline retinal disease 1
• Do not continue pre-pregnancy insulin doses postpartum - dramatic dose reduction is needed immediately after delivery to prevent severe hypoglycemia 1
• Do not discharge the newborn without 24-48 hours of glucose monitoring - neonatal hypoglycemia may not manifest immediately 6, 3